A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response ...

New research shows that reducing dietary protein may significantly lower liver cancer risk or slow its progression in people ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

Ochsner MD Anderson Cancer Center has begun offering a newly approved, non-invasive treatment for certain liver tumors, making it one of a limited number of hospitals nationwide to provide the ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple dietary change: eating less protein. A Rutgers-led study in Science ...

What if cutting off a tumor’s fat supply could also rally the immune system to join the fight? Liver cancer fueled by fatty liver disease is on the rise, and with low survival rates, new treatment ...

Liver cancer is increasingly affecting non-drinkers in India. Doctor explains how fatty liver disease, diabetes, hepatitis ...

Researchers assess the cost‐effectiveness of nivolumab plus ipilimumab vs lenvatinib or sorafenib for hepatocellular carcinoma from a US healthcare payer perspective.

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still requires a good multidisciplinary team, like any cancer treatment, said ...

UChicago Medicine is using a new technology to destroy liver tumors without radiation, chemotherapy or even cutting the skin. Called histotripsy, it destroys tumors using sound waves. Amber Sikes was ...

Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...